{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:42:20Z","timestamp":1793407340563,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"JSPS Grant-in-Aid for Scientific Research","award":["JP23K06697"],"award-info":[{"award-number":["JP23K06697"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosurg Rev"],"DOI":"10.1007\/s10143-023-02234-7","type":"journal-article","created":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T04:28:28Z","timestamp":1701318508000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Differences in invasiveness and recurrence rate among nonfunctioning pituitary neuroendocrine tumors depending on tumor subtype"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2450-5674","authenticated-orcid":false,"given":"Akira","family":"Taguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishwa Jeet","family":"Amatya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumpei","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiyuki","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,30]]},"reference":[{"key":"2234_CR1","unstructured":"(2014) Brain tumor registry of Japan (2001\u20132004). Neurol Med Chir\u00a0(Tokyo)\u00a054(Suppl):1\u2013102.\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4740110\/"},{"key":"2234_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa SL, Mete O, Perry A, Osamura RY (2022) Overview of the 2022 WHO classification of pituitary tumors. Endocr Pathol 33:6\u201326. https:\/\/doi.org\/10.1007\/s12022-022-09703-7","journal-title":"Endocr Pathol"},{"key":"2234_CR3","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1507\/endocrj.EJ23-0007","volume":"70","author":"H Nishioka","year":"2023","unstructured":"Nishioka H (2023) Aggressive pituitary tumors (PitNETs). Endocr J 70:241\u2013248. https:\/\/doi.org\/10.1507\/endocrj.EJ23-0007","journal-title":"Endocr J"},{"key":"2234_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","volume":"126","author":"J Trouillas","year":"2013","unstructured":"Trouillas J, Roy P, Sturm N et al (2013) A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol 126:123\u2013135. https:\/\/doi.org\/10.1007\/s00401-013-1084-y","journal-title":"Acta Neuropathol"},{"key":"2234_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11102-018-0869-3","volume":"21","author":"G Ntali","year":"2018","unstructured":"Ntali G, Wass JA (2018) Epidemiology, clinical presentation and diagnosis of non-functioning pituitary adenomas. Pituitary 21:111\u2013118. https:\/\/doi.org\/10.1007\/s11102-018-0869-3","journal-title":"Pituitary"},{"key":"2234_CR6","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/cancers12020514","volume":"12","author":"J Trouillas","year":"2020","unstructured":"Trouillas J, Jaffrain-Rea ML, Vasiljevic A, Raverot G, Roncaroli F, Villa C (2020) How to classify the pituitary neuroendocrine tumors (PitNET)s in 2020. Cancers (Basel) 12:514. https:\/\/doi.org\/10.3390\/cancers12020514","journal-title":"Cancers (Basel)"},{"key":"2234_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1227\/01.NEU.0000290906.53685.79","volume":"61","author":"S Yamada","year":"2007","unstructured":"Yamada S, Ohyama K, Taguchi M et al (2007) A study of the correlation between morphological findings and biological activities in clinically nonfunctioning pituitary adenomas. Neurosurgery 61:580\u2013584. https:\/\/doi.org\/10.1227\/01.NEU.0000290906.53685.79","journal-title":"Neurosurgery"},{"key":"2234_CR8","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1007\/s12022-015-9398-z","volume":"26","author":"H Nishioka","year":"2015","unstructured":"Nishioka H, Inoshita N, Mete O et al (2015) The complementary role of transcription factors in the accurate diagnosis of clinically nonfunctioning pituitary adenomas. Endocr Pathol 26:349\u2013355. https:\/\/doi.org\/10.1007\/s12022-015-9398-z","journal-title":"Endocr Pathol"},{"key":"2234_CR9","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.3171\/2020.3.FOCUS20114","volume":"48","author":"AF Haddad","year":"2020","unstructured":"Haddad AF, Young JS, Oh T et al (2020) Clinical characteristics and outcomes of null-cell versus silent gonadotroph adenomas in a series of 1166 pituitary adenomas from a single institution. Neurosurg Focus 48:E13. https:\/\/doi.org\/10.3171\/2020.3.FOCUS20114","journal-title":"Neurosurg Focus"},{"key":"2234_CR10","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s10143-022-01915-z","volume":"46","author":"A Taguchi","year":"2022","unstructured":"Taguchi A, Kinoshita Y, Tokumo K et al (2022) Usefulness of critical flicker fusion frequency measurement and its laterality for evaluating compressive optic neuropathy due to pituitary neuroendocrine tumors. Neurosurg Rev 46:4. https:\/\/doi.org\/10.1007\/s10143-022-01915-z","journal-title":"Neurosurg Rev"},{"key":"2234_CR11","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1227\/00006123-199310000-00008","volume":"33","author":"E Knosp","year":"1993","unstructured":"Knosp E, Steiner E, Kitz K, Matula C (1993) Pituitary adenomas with invasion of the cavernous sinus space: A magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33:610\u2013617. https:\/\/doi.org\/10.1227\/00006123-199310000-00008","journal-title":"Neurosurgery"},{"key":"2234_CR12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.wneu.2016.07.036","volume":"93","author":"Y Kinoshita","year":"2016","unstructured":"Kinoshita Y, Tominaga A, Usui S et al (2016) The surgical side effects of pseudocapsular resection in nonfunctioning pituitary adenomas. World Neurosurg 93:430\u2013435. https:\/\/doi.org\/10.1016\/j.wneu.2016.07.036","journal-title":"World Neurosurg"},{"key":"2234_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1038\/s41379-018-0167-7","volume":"32","author":"O Mete","year":"2019","unstructured":"Mete O, Kefeli M, \u00c7al\u0131\u015fkan S, Asa SL (2019) GATA3 immunoreactivity expands the transcription factor profile of pituitary neuroendocrine tumors. Mod Pathol 32:484\u2013489. https:\/\/doi.org\/10.1038\/s41379-018-0167-7","journal-title":"Mod Pathol"},{"key":"2234_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1007\/s12022-020-09615-4","volume":"31","author":"J Turchini","year":"2020","unstructured":"Turchini J, Sioson L, Clarkson A, Sheen A, Gill AJ (2020) Utility of GATA-3 expression in the analysis of pituitary neuroendocrine tumour (PitNET) transcription factors. Endocr Pathol 31:150\u2013155. https:\/\/doi.org\/10.1007\/s12022-020-09615-4","journal-title":"Endocr Pathol"},{"key":"2234_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11060-014-1425-2","volume":"117","author":"SE Mayson","year":"2014","unstructured":"Mayson SE, Snyder PJ (2014) Silent (clinically nonfunctioning) pituitary adenomas. J Neurooncol 117:429\u2013436. https:\/\/doi.org\/10.1007\/s11060-014-1425-2","journal-title":"J Neurooncol"},{"key":"2234_CR16","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11102-021-01133-8","volume":"24","author":"S Jiang","year":"2021","unstructured":"Jiang S, Zhu J, Feng M et al (2021) Clinical profiles of silent corticotroph adenomas compared with silent gonadotroph adenomas after adopting the 2017 WHO pituitary classification system. Pituitary 24:564\u2013573. https:\/\/doi.org\/10.1007\/s11102-021-01133-8","journal-title":"Pituitary"},{"key":"#cr-split#-2234_CR17.1","doi-asserted-by":"crossref","unstructured":"Anat Ben-Shlomo SM (2011) Chapter 2: Hypothalamic regulation of anterior pituitary function. In: Anat Ben-Shlomo, Shlomo Melmed.","DOI":"10.1016\/B978-0-12-380926-1.10002-1"},{"key":"#cr-split#-2234_CR17.2","unstructured":"(ed) The Pituitary (Third edition), pp. 21-45. Academic Press (2011), https:\/\/www.academia.edu\/19700586\/The_Pituitary_3rd_Edition. Accessed 22 June 2023."},{"key":"2234_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s40478-022-01437-1","volume":"10","author":"LG Perez-Rivas","year":"2022","unstructured":"Perez-Rivas LG, Simon J, Albani A et al (2022) TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome. Acta Neuropathol Commun 10:139. https:\/\/doi.org\/10.1186\/s40478-022-01437-1","journal-title":"Acta Neuropathol Commun"},{"key":"2234_CR19","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1530\/EJE-17-0933","volume":"178","author":"A McCormack","year":"2018","unstructured":"McCormack A, Dekkers OM, Petersenn S et al (2018) Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016. Eur J Endocrinol 178:265\u2013276. https:\/\/doi.org\/10.1530\/EJE-17-0933","journal-title":"Eur J Endocrinol"},{"key":"2234_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2023.3.JNS221949","volume":"28","author":"K Asmaro","year":"2023","unstructured":"Asmaro K, Zhang M, Rodrigues AJ et al (2023) Cytodifferentiation of pituitary tumors influences pathogenesis and cavernous sinus invasion. J Neurol Surg 28:1\u20139. https:\/\/doi.org\/10.3171\/2023.3.JNS221949","journal-title":"J Neurol Surg"},{"key":"2234_CR21","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3171\/2014.3.JNS132214","volume":"121","author":"H Nishioka","year":"2014","unstructured":"Nishioka H, Fukuhara N, Horiguchi K, Yamada S (2014) Aggressive transsphenoidal resection of tumors invading the cavernous sinus in patients with acromegaly: predictive factors, strategies, and outcomes. J Neurosurg 121:505\u2013510. https:\/\/doi.org\/10.3171\/2014.3.JNS132214","journal-title":"J Neurosurg"},{"key":"2234_CR22","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11102-017-0858-y","volume":"21","author":"F Langlois","year":"2018","unstructured":"Langlois F, Woltjer R, Cetas JS, Fleseriu M (2018) Silent somatotroph pituitary adenomas: an update. Pituitary 21:194\u2013202. https:\/\/doi.org\/10.1007\/s11102-017-0858-y","journal-title":"Pituitary"},{"key":"2234_CR23","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11102-018-0921-3","volume":"22","author":"G Cossu","year":"2019","unstructured":"Cossu G, Daniel RT, Pierzchala K et al (2019) Thyrotropin-secreting pituitary adenomas: a systematic review and meta-analysis of postoperative outcomes and management. Pituitary 22:79\u201388. https:\/\/doi.org\/10.1007\/s11102-018-0921-3","journal-title":"Pituitary"},{"key":"2234_CR24","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s12020-020-02556-2","volume":"73","author":"A Taguchi","year":"2021","unstructured":"Taguchi A, Kinoshita Y, Yamasaki F, Arita K, Tominaga A (2021) Clinical characteristics and thyroid hormone dynamics of thyrotropin-secreting pituitary adenomas at a single institution. Endocrine 73:151\u2013159. https:\/\/doi.org\/10.1007\/s12020-020-02556-2","journal-title":"Endocrine"},{"key":"2234_CR25","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.3171\/2014.7.JNS1471","volume":"121","author":"S Yamada","year":"2014","unstructured":"Yamada S, Fukuhara N, Horiguchi K et al (2014) Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases. J Neurosurg 121:1462\u20131473. https:\/\/doi.org\/10.3171\/2014.7.JNS1471","journal-title":"J Neurosurg"},{"key":"2234_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1159\/000499382","volume":"109","author":"J Trouillas","year":"2019","unstructured":"Trouillas J, Delgrange E, Wierinckx A et al (2019) Clinical, pathological, and molecular factors of aggressiveness in lactotroph tumours. Neuroendocrinology 109:70\u201376. https:\/\/doi.org\/10.1159\/000499382","journal-title":"Neuroendocrinology"},{"key":"2234_CR27","doi-asserted-by":"publisher","first-page":"9919","DOI":"10.1038\/s41598-022-12980-1","volume":"12","author":"A Mohyeldin","year":"2022","unstructured":"Mohyeldin A, Katznelson LJ, Hoffman AR et al (2022) Prospective intraoperative and histologic evaluation of cavernous sinus medial wall invasion by pituitary adenomas and its implications for acromegaly remission outcomes. Sci Rep 12:9919. https:\/\/doi.org\/10.1038\/s41598-022-12980-1","journal-title":"Sci Rep"},{"key":"2234_CR28","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12022-017-9503-6","volume":"28","author":"JC Lee","year":"2017","unstructured":"Lee JC, Pekmezci M, Lavezo JL et al (2017) Utility of Pit-1 immunostaining in distinguishing pituitary adenomas of primitive differentiation from null cell adenomas. Endocr Pathol 28:287\u2013292. https:\/\/doi.org\/10.1007\/s12022-017-9503-6","journal-title":"Endocr Pathol"},{"key":"2234_CR29","first-page":"379","volume":"118","author":"RV Lloyd","year":"1985","unstructured":"Lloyd RV, Landefeld TD, Maslar I, Frohman LA (1985) Diethylstilbestrol inhibits tumor growth and prolactin production in rat pituitary tumors. Am J Pathol 118:379\u2013386","journal-title":"Am J Pathol"},{"key":"2234_CR30","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1227\/neu.0000000000002109","volume":"91","author":"A Ishida","year":"2022","unstructured":"Ishida A, Shiramizu H, Yoshimoto H et al (2022) Resection of the cavernous sinus medial wall improves remission rate in functioning pituitary tumors: retrospective analysis of 248 consecutive cases. Neurosurgery 91:775\u2013781. https:\/\/doi.org\/10.1227\/neu.0000000000002109","journal-title":"Neurosurgery"},{"key":"2234_CR31","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1002\/cjp2.340","volume":"9","author":"J Zhao","year":"2023","unstructured":"Zhao J, Ji C, Cheng H et al (2023) Digital image analysis allows objective stratification of patients with silent PIT1-lineage pituitary neuroendocrine tumors. J Pathol Clin Res 9:488\u2013497. https:\/\/doi.org\/10.1002\/cjp2.340","journal-title":"J Pathol Clin Res"},{"key":"2234_CR32","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1093\/ejendo\/lvad079","volume":"189","author":"NF Lenders","year":"2023","unstructured":"Lenders NF, Earls PE, Wilkinson AC et al (2023) Predictors of pituitary tumour behaviour: an analysis from long-term follow-up in 2 tertiary centres. Eur J Endocrinol 189:106\u2013114. https:\/\/doi.org\/10.1093\/ejendo\/lvad079","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 2","key":"2234_CR33","doi-asserted-by":"publisher","first-page":"e580","DOI":"10.1055\/s-0041-1735874","volume":"83","author":"K Tadokoro","year":"2022","unstructured":"Tadokoro K, Wolf C, Toth J et al (2022) Ki-67\/MIB-1 and recurrence in pituitary adenoma. J Neurol Surg B Skull Base 83(Suppl 2):e580\u2013e590. https:\/\/doi.org\/10.1055\/s-0041-1735874","journal-title":"J Neurol Surg B Skull Base"},{"key":"2234_CR34","doi-asserted-by":"publisher","first-page":"3131","DOI":"10.1007\/s00701-021-04953-6","volume":"163","author":"S Ng","year":"2021","unstructured":"Ng S, Messerer M, Engelhardt J et al (2021) Aggressive pituitary neuroendocrine tumors: current practices, controversies, and perspectives, on behalf of the EANS skull base section. Acta Neurochir (Wien) 163:3131\u20133142. https:\/\/doi.org\/10.1007\/s00701-021-04953-6","journal-title":"Acta Neurochir (Wien)"}],"container-title":["Neurosurgical Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-023-02234-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10143-023-02234-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10143-023-02234-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T18:19:32Z","timestamp":1705947572000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10143-023-02234-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,30]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2234"],"URL":"https:\/\/doi.org\/10.1007\/s10143-023-02234-7","relation":{},"ISSN":["1437-2320"],"issn-type":[{"value":"1437-2320","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,30]]},"assertion":[{"value":"12 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted retrospectively, utilized data obtained for clinical purposes, and was approved by the ethics committee of Hiroshima University Hospital (E-2022, May 18, 2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"As patient data in this study are completely anonymized, any identification of individuals is difficult. Pertinent research content is available in the homepage of our institution.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving participants and\/or animals"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"317"}}